Last reviewed · How we verify
Platelet rich fibrin matrix
Platelet rich fibrin matrix is a Biologic drug developed by The New York Eye & Ear Infirmary. It is currently in Phase 1 development. Also known as: Selphyl.
At a glance
| Generic name | Platelet rich fibrin matrix |
|---|---|
| Also known as | Selphyl |
| Sponsor | The New York Eye & Ear Infirmary |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Biologicals in Management of Intra-Bony Defects (NA)
- Efficacy Of Eggshell-Derived Nanohydroxyapatite Based Mineralized Plasmatic Matrix Versus Xenogeneic Based Mineralized Plasmatic Matrix in Posterior Mandibular Socket Preservation (NA)
- Autogenous Tooth Transplantation With Instrumentally Simulated Open Apex and Platelet-Rich Fibrin (NA)
- VCMX, PRF and SCTG Treatment in the Gingival Recessions (PHASE3)
- Effect of I-PRF Application on ALP and MMP-9 Levels in Teeth With Apical Periodontitis
- Application of Growth Factors Derived From Platelets to Accelerate Healing and Reduce Post-extraction Complications in Diabetic Individuals (NA)
- Treatment of Spinal Cord Injury Using Autologous Concentrated Growth Factors (EARLY_PHASE1)
- Demineralized Dentin Matrix Versus Mineralized Plasmatic Matrix on Alveolar Ridge Preservation in Molar Extraction Sites (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Platelet rich fibrin matrix CI brief — competitive landscape report
- Platelet rich fibrin matrix updates RSS · CI watch RSS
- The New York Eye & Ear Infirmary portfolio CI
Frequently asked questions about Platelet rich fibrin matrix
What is Platelet rich fibrin matrix?
Platelet rich fibrin matrix is a Biologic drug developed by The New York Eye & Ear Infirmary.
Who makes Platelet rich fibrin matrix?
Platelet rich fibrin matrix is developed by The New York Eye & Ear Infirmary (see full The New York Eye & Ear Infirmary pipeline at /company/the-new-york-eye-ear-infirmary).
Is Platelet rich fibrin matrix also known as anything else?
Platelet rich fibrin matrix is also known as Selphyl.
What development phase is Platelet rich fibrin matrix in?
Platelet rich fibrin matrix is in Phase 1.
Related
- Manufacturer: The New York Eye & Ear Infirmary — full pipeline
- Also known as: Selphyl
- Compare: Platelet rich fibrin matrix vs similar drugs
- Pricing: Platelet rich fibrin matrix cost, discount & access